Chemoinformaics analysis of TRANS-5-OCTADECENOIC ACID
| Molecular Weight | 282.468 | nRot | 15 |
| Heavy Atom Molecular Weight | 248.196 | nRig | 2 |
| Exact Molecular Weight | 282.256 | nRing | 0 |
| Solubility: LogS | -5.595 | nHRing | 0 |
| Solubility: LogP | 7.146 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 54.335 |
| nHD | 1 | BPOL | 34.977 |
| QED | 0.291 |
| Synth | 2.038 |
| Natural Product Likeliness | 0.899 |
| NR-PPAR-gamma | 0.983 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.007 |
| CACO-2 | -4.921 |
| MDCK | 0.0000234 |
| BBB | 0.101 |
| PPB | 0.987728 |
| VDSS | 0.736 |
| FU | 0.0125663 |
| CYP1A2-inh | 0.322 |
| CYP1A2-sub | 0.183 |
| CYP2c19-inh | 0.174 |
| CYP2c19-sub | 0.069 |
| CYP2c9-inh | 0.261 |
| CYP2c9-sub | 0.989 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.068 |
| CYP3a4-inh | 0.052 |
| CYP3a4-sub | 0.017 |
| CL | 2.505 |
| T12 | 0.533 |
| hERG | 0.038 |
| Ames | 0.004 |
| ROA | 0.016 |
| SkinSen | 0.95 |
| Carcinogencity | 0.083 |
| EI | 0.972 |
| Respiratory | 0.708 |
| NR-Aromatase | 0.153 |
| Antiviral | Yes |
| Prediction | 0.576912 |